Table 1. Clinical characteristics of the PSPs.
| PID | DOB | Trans mission | Sex | C or M | HLA-A | HLA-A | HLA-B | HLA-B | HLA-C | HLA-C | Early ART duration | Early ART start (age) | Early ART stop (age) | ART (re)start age | Type of slow progression |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| yr | yr | yr | yr | ||||||||||||
| 133-C | 11/2003 | IU | f | C | 68:01 | 74:01 | 58:02 | 81:01 | 04:01 | 06:02 | none | n/a | n/a | left study at 9 yr, no ART | VC group |
| M | 03:01 | 68:01 | 42:01 | 58:02 | 06:02 | 12:04 | |||||||||
| 468-C | 12/2004 | IU | m | C | 02:02 | 68:01 | 57:03 | 58:01 | 06:02 | 07:01 | 1.5 | 0.1 | 1.6 | 6.1 | |
| M | 34:02 | 68:01 | 44:03 | 58:01 | 04:01 | 06:02 | |||||||||
| 349-C | 11/2004 | IU | f | C | 23:01 | 43:01 | 45:01 | 58:02 | 06:02 | 06:02 | none | n/a | n/a | 9 | |
| M | 23:01 | 30:02 | 45:01 | 57:02 | 06:02 | 07:01 | |||||||||
| 364-C | 09/2004 | IU | f | C | 29:02 | 30:02 | 41:02 | 44:03 | 07:01 | 17:01 | 1.5 | 0.2 | 1.7 | 8 | |
| M | 03:01 | 29:02 | 35:01 | 44:03 | 04:01 | 07:01 | |||||||||
| 385-C | 01/2005 | IP | f | C | 30:01 | 34:02 | 15:03 | 58:02 | 02:10 | 06:02 | 1.3 | 0.3 | 1.6 | left study at 8 yr, no ART | |
| M | 30:01 | 43:01 | 15:03 | 58:02 | 02:02 | 06:02 | |||||||||
| 517-C | 01/2005 | IP | m | C | 30:02 | 68:02 | 15:10 | 42:01 | 03:04 | 17:01 | none | n/a | n/a | never | VNC group |
| M | 30:02 | 30:04 | 42:01 | 58:02 | 06:02 | 17:01 | |||||||||
| 021-C | 09/2005 | IU | f | C | 02:05 | 29:02 | 42:01 | 44:03 | 02:10 | 17:01 | 1.0 | 0.1 | 1.1 | never | |
| M | 02:05 | 33:01 | 42:01 | 44:03 | 02:10 | 17:01 | |||||||||
| 114-C | 09/2003 | IP | f | C | 03:01 | 24:02 | 07:02 | 08:01 | 07:01 | 07:02 | 1.0 | 0.1 | 1.1 | left study at 7.3 yr, no ART | |
| M | 03:01 | 68:02 | 08:01 | 57:02 | 07:01 | 18:01 | |||||||||
| 559-C | 02/2005 | IU | m | C | 23:01 | 68:02 | 08:01 | 58:01 | 07:01 | 07:01 | 1.0 | 0.1 | 1.1 | 5.2 | |
| M | 23:01 | 30:02 | 08:01 | 58:02 | 06:02 | 07:01 | |||||||||
| 380-C | 10/2004 | IU | m | C | 23:01 | 68:02 | 15:10 | 15:10 | 03:04 | 08:01 | 1.1 | 0.1 | 1.2 | 7.6 | |
| M | 02:00 | 23:01 | 07:02 | 15:10 | 03:04 | 04:01 | |||||||||
| 081-C | 08/2003 | IU | f | C | 29:02 | 68:02 | 15:16 | 44:03 | 03:04 | 07:01 | 1.4 | 0.1 | 1.5 | 6.7 | |
| M | 29:02 | 30:01 | 42:02 | 44:03 | 07:01 | 17:01 |
For each subject, child’s HLA type is shown in the first row and maternal HLA is in the second row. C, child; DOB, date of birth; f, female; IP, intrapartum infection; IU, in utero infection; m, male; M, mother; n/a, not applicable; PID, participant identification.